@article{ac0997d7dafe4ea5bdf55d4b8bac9ac4,
title = "High treatment persistence rate and significant endoscopic healing among real-life patients treated with vedolizumab - a Finnish Nationwide Inflammatory Bowel Disease Cohort Study (FINVEDO)",
keywords = "Biological therapy, Crohn's disease, endoscopy, real-world effectiveness, ulcerative colitis, vedolizumab, EFFICACY END-POINTS, CROHNS-DISEASE, MAINTENANCE THERAPY, ULCERATIVE-COLITIS, FECAL CALPROTECTIN, INDUCTION THERAPY, ACTIVITY INDEXES, MEDICAL THERAPY, CLINICAL-TRIALS, REMISSION, 3121 General medicine, internal medicine and other clinical medicine",
author = "Tero Ylisaukko-oja and Jaakko Aaltonen and Heikki Nuutinen and Timo Blomster and Airi Jussila and Markku Pajala and Kimmo Salminen and Veikko Moilanen and Kalle Hakala and Mikko Kellokumpu and Kari Toljamo and Henna Rautiainen and Juha Kuisma and Markku Per{\"a}aho and Pauliina Molander and Jouni Silvennoinen and Ville Liukkonen and Hans Henricson and Jyrki Tillonen and Mirva Esterinen and Christian Nielsen and Eija Hirsi and Margus L{\"a}{\"a}ne and Ulla-Maija Suhonen and Ilkka Vihri{\"a}l{\"a} and Petri M{\"a}kel{\"a} and Mika Puhto and Jari Punkkinen and Hannu Sulonen and Sauli Herrala and Jari Jokelainen and Klaus Tamminen and Taina Sipponen",
year = "2018",
doi = "10.1080/00365521.2017.1416160",
language = "English",
volume = "53",
pages = "158--167",
journal = "Scandinavian Journal of Gastroenterology",
issn = "0036-5521",
publisher = "Informa healthcare",
number = "2",
}